# Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia

> **NCT05371639** · PHASE2 · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 360 (estimated)

## Conditions studied

- Vascular Dementia
- Cognitive Impairment

## Interventions

- **DRUG:** Tian Ma Bian Chun Zhi Gan Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05371639
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-25
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371639, "Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05371639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*